Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety
The DOI matches its Crossref record.
Abstract
Evidence from clinical trials supports the claim that sertindole is a potent antipsychotic drug at a dose of 12-24 mg/day. Its action against positive symptoms is as potent as that of the traditional antipsychotic haloperidol. Its action against negative symptoms is significantly different from that of placebo and quantitatively larger than that of haloperidol. Its most distinctive characteristic is a reduction in motor side effects over a whole range of comparable drug and comparator doses. More work is needed to determine whether sertindole's actions against negative symptoms influence the primary or the secondary negative system. There are insufficient data at present to compare sertindole with the highly efficacious drug clozapine or the other new antipsychotic olanzapine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Leucht, S., Pitschel-Walz, G., Abraham, D., & Kissling, W. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00105-4 · Cited by 796
Sexuality and Schizophrenia: A Review
Kelly, D. L., & Conley, R. R. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007130 · Cited by 164
“Cholinergic antagonism and alpha-adrenergic blockade have been implicated in orgasmic dysfunction and ejaculatory disturbances (Pollack and Rosenbaum 1992; Tamminga et al. 1997).”
BackgroundRodefer, J. S., Nguyen, T. N., Karlsson, J.-J., & Arnt, J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301654 · Cited by 126
“In addition, plasma levels of sertindole after the minimal effective dose (1.3 mg/ kg) were within the range of exposures obtained in clinical studies of sertindole (35–100 ng/ml; Tamminga et al, 1997).”
BackgroundInfluentialThomas, S. H. L., Drici, M. D., Hall, G. C., Crocq, M. A., Everitt, B., Lader, M. H., Jeunne, C. L., Naber, D., Priori, S., Sturkenboom, M., et al. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01563.x · Cited by 67
Metadata
- Authors
- Tamminga, C. A., Mack, R. J., Granneman, G. R., Silber, C. J., & Kashkin, K. B.
- Venue
- International Clinical Psychopharmacology
- Published
- 1997-02
- Volume
- 12
- Pages
- S29-S36
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2011989818
- Cited by
- 36
- References
- 0
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety. https://app.cochat.ai/papers/10.1097/00004850-199702001-00005
- The paper
- Tamminga, C. A., Mack, R. J., Granneman, G. R., Silber, C. J., & Kashkin, K. B. (1997). Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199702001-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.